Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?



To: kenhott who wrote (33963)3/5/2010 1:45:00 AM
From: BulbaManRespond to of 40234
 
Thanks for the post Ken.
For those who didn't catch the links posted earlier, the Dr. Keith Flaherty mentioned in the piece was also a focus of a recent NYT three-part series. Here's a link to Part I, from which you can get to the rest of the article:
nytimes.com 
Peace & good health,
Bulba


Copyright © 1995-2013 Knight Sac Media. All rights reserved.